Evidence map›Paper›PMID 24122827›Full record

ArticleHepatology (Baltimore, Md.)2014

Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.

Li Chen, Alyssa Charrier, Yu Zhou, Ruju Chen, Bo Yu, Kitty Agarwal, Hidekazu Tsukamoto, L James Lee, Michael E Paulaitis, David R Brigstock

Abstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 1 synthesis or guideline pooled it, 264 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Epigenetic Mechanisms in Heart Diseases.Reviews in cardiovascular medicine · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Sinusoidal communication in chronic liver disease.Clinical and molecular hepatology · 2025
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Li ChenResearch Institute at Nationwide Children's Hospital, Columbus, OH.
Alyssa Charrier
Yu Zhou
Ruju Chen
Bo Yu
Kitty Agarwal
Hidekazu Tsukamoto
L James Lee
Michael E Paulaitis
David R Brigstock
Nationwide Children's Hospital · USThe Ohio State University · USUniversity of Southern California · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
Mechanisms of CTGF-Induced Liver DiseaseR01AA016003 · NIAAA · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BRIGSTOCK, DAVID R · 2007 to 2011
$1.7M
MicroRNA regulation of CTGF in hepatic stellate cellsR01AA021276 · NIAAA · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BRIGSTOCK, DAVID R · 2012 to 2016
$1.6M
NCI NIH HHS P30 CA016058NIAAA NIH HHS P50AA011099NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA016003NIAAA NIH HHS R01 AA021276
6 · The paper itself

Abstract

unlabelledConnective tissue growth factor (CCN2) drives fibrogenesis in hepatic stellate cells (HSC). Here we show that CCN2 up-regulation in fibrotic or steatotic livers, or in culture-activated or ethanol-treated primary mouse HSC, is associated with a reciprocal down-regulation of microRNA-214 (miR-214). By using protector or reporter assays to investigate the 3'-untranslated region (UTR) of CCN2 mRNA, we found that induction of CCN2 expression in HSC by fibrosis-inducing stimuli was due to reduced expression of miR-214, which otherwise inhibited CCN2 expression by directly binding to the CCN2 3'-UTR. Additionally, miR-214 was present in HSC exosomes, which were bi-membrane vesicles, 50-150 nm in diameter, negatively charged (-26 mV), and positive for CD9. MiR-214 levels in exosomes but not in cell lysates were reduced by pretreatment of the cells with the exosome inhibitor, GW4869. Coculture of either quiescent HSC or miR-214-transfected activated HSC with CCN2 3'-UTR luciferase reporter-transfected recipient HSC resulted in miR-214- and exosome-dependent regulation of a wild-type CCN2 3'-UTR reporter but not of a mutant CCN2 3'-UTR reporter lacking the miR-214 binding site. Exosomes from HSC were a conduit for uptake of miR-214 by primary mouse hepatocytes. Down-regulation of CCN2 expression by miR-214 also occurred in human LX-2 HSC, consistent with a conserved miR-214 binding site in the human CCN2 3'-UTR. MiR-214 in LX-2 cells was shuttled by way of exosomes to recipient LX-2 cells or human HepG2 hepatocytes, resulting in suppression of CCN2 3'-UTR activity or expression of CCN2 downstream targets, including alpha smooth muscle actin or collagen. Experimental fibrosis in mice was associated with reduced circulating miR-214 levels.

conclusionExosomal transfer of miR-214 is a paradigm for the regulation of CCN2-dependent fibrogenesis and identifies fibrotic pathways as targets of intercellular regulation by exosomal miRs.

Indexed as

Chemical and Drug Induced Liver Injury3' Untranslated RegionsAniline CompoundsAnimalsBenzylidene CompoundsCoculture TechniquesConnective Tissue Growth FactorEpigenesis, GeneticExosomesHepatic Stellate CellsHep G2 CellsHumansLiver CirrhosisMiceMicroRNAsPrimary Cell Culture3' Untranslated RegionsAniline CompoundsBenzylidene CompoundsCCN2 protein, humanCCN2 protein, mouseConnective Tissue Growth FactorGW 4869MicroRNAsMIRN214 microRNA, humanMirn214 microRNA, mouseRNA, Messenger

Identifiers

PMID24122827
PMCPMC3943742
OpenAlexW2062410076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.